Multimodal predictors for precision immunotherapy

Immune checkpoint blockade (ICB) unleashes immune cells to attack tumors, thereby inducing durable clinical responses in many cancer types. The number of patients responding to ICB is modest, however, and combination treatments are likely needed to overcome the multifaceted suppressive pathways acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Roelofsen, L.M., Kaptein, P., Thommen, D.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216437/
https://www.ncbi.nlm.nih.gov/pubmed/35755892
http://dx.doi.org/10.1016/j.iotech.2022.100071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9216437/
https://www.ncbi.nlm.nih.gov/pubmed/35755892
http://dx.doi.org/10.1016/j.iotech.2022.100071

Ejemplares similares